AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend

AbbVie Inc. (NYSE:ABBV) reported third-quarter 2025 sales of $15.78 billion on Friday, beating the consensus of $15.59 billion.Sales increased 9.1% on a reported basis or 8.4% on an operational basis. The company reported adjusted earnings of $1.86 per share, down 38%, beating the consensus of $1.79.Dividend: AbbVie increased its quarterly dividend from $1.64 per share to $1.73.“AbbVie continues to deliver outstanding results, with significant momentum across key areas of our portfolio. We are also making g ...